Rolontis

Bio & Pharma Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Bio & Pharma FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...